BIOMAT Database Logo BIOMAT Database Logo

[Chronobiological study of the antihypertensive effect of captopril-hydrochlorothiazide combination administered in a single low dose]. 1988

P Cugini, and C Di Veroli, and L Di Palma, and P Battisti

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006852 Hydrochlorothiazide A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. Dichlothiazide,Dihydrochlorothiazide,Esidrex,Esidrix,HCTZ,HydroDIURIL,Hypothiazide,Oretic,Sectrazide

Related Publications

P Cugini, and C Di Veroli, and L Di Palma, and P Battisti
Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group.
April 1994, Archives of internal medicine,
P Cugini, and C Di Veroli, and L Di Palma, and P Battisti
[Combination captopril-hydrochlorothiazide in a single dose for treatment of essential arterial hypertension].
February 1988, Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
P Cugini, and C Di Veroli, and L Di Palma, and P Battisti
A "lipo-protective" effect of a fixed combination of captopril and hydrochlorothiazide in antihypertensive therapy.
September 1992, Clinical cardiology,
P Cugini, and C Di Veroli, and L Di Palma, and P Battisti
Duration of antihypertensive effect of a single daily dose of hydrochlorothiazide.
March 1980, Clinical pharmacology and therapeutics,
P Cugini, and C Di Veroli, and L Di Palma, and P Battisti
[Validity and effectiveness of a pre-constituted captopril-hydrochlorothiazide combination in a single daily dose].
October 1986, La Clinica terapeutica,
P Cugini, and C Di Veroli, and L Di Palma, and P Battisti
Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
March 1998, Journal of cardiovascular pharmacology,
P Cugini, and C Di Veroli, and L Di Palma, and P Battisti
[Multicenter study of the efficacy of 3 antihypertensive regimens: captopril + hydrochlorothiazide, oxprenolol + hydrochlorothiazide, and alphamethyldopa + hydrochlorothiazide].
November 1985, Medicina clinica,
P Cugini, and C Di Veroli, and L Di Palma, and P Battisti
[Comparison of the antihypertensive effectiveness of captopril in combination with various doses of hydrochlorothiazide].
December 1988, Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
P Cugini, and C Di Veroli, and L Di Palma, and P Battisti
Relation between low dose of hydrochlorothiazide, antihypertensive effect and adverse effects.
July 1994, Blood pressure,
P Cugini, and C Di Veroli, and L Di Palma, and P Battisti
Antihypertensive effect of a fixed-dose combination of losartan/hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study.
April 2012, Clinical and experimental nephrology,
Copied contents to your clipboard!